EDMUND SCOTT KOPETZ's research topics

EDMUND SCOTT KOPETZ

Concepts (422)

Back to Profile

Concepts are derived automatically from a person's publications.

The timeline below shows the dates (blue tick marks) of publications associated with EDMUND SCOTT KOPETZ's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that EDMUND SCOTT KOPETZ has written about over time.

src-Family Kinases, 4 publications between 2007 and 2010, average publication date January 2009. Organoplatinum Compounds, 15 publications between 2008 and 2014, average publication date October 2010. Antineoplastic Combined Chemotherapy Protocols, 34 publications between 2007 and 2022, average publication date January 2011. Antineoplastic Agents, 24 publications between 2005 and 2022, average publication date March 2011. Hepatectomy, 18 publications between 2007 and 2014, average publication date May 2011. Drug Resistance, Neoplasm, 8 publications between 2008 and 2013, average publication date August 2011. Vascular Endothelial Growth Factor A, 3 publications between 2009 and 2013, average publication date August 2011. Liver Neoplasms, 26 publications between 2007 and 2014, average publication date September 2011. Colorectal Neoplasms, 66 publications between 2005 and 2022, average publication date January 2012. Colonic Neoplasms, 11 publications between 2008 and 2020, average publication date August 2012. Proto-Oncogene Proteins, 12 publications between 2009 and 2015, average publication date March 2013. ras Proteins, 13 publications between 2009 and 2015, average publication date April 2013. Biomarkers, Tumor, 15 publications between 2008 and 2017, average publication date July 2013. Indoles, 3 publications between 2011 and 2015, average publication date July 2013. Phosphatidylinositol 3-Kinases, 7 publications between 2011 and 2015, average publication date October 2013. Proto-Oncogene Proteins B-raf, 17 publications between 2011 and 2022, average publication date May 2014. Mutation, 26 publications between 2011 and 2022, average publication date October 2014. Sulfonamides, 4 publications between 2011 and 2022, average publication date October 2015. Benzimidazoles, 3 publications between 2012 and 2022, average publication date November 2018.

src-Family Kinases
Organoplatinum Compounds
Antineoplastic Combined Chemotherapy Protocols
Antineoplastic Agents
Hepatectomy
Drug Resistance, Neoplasm
Vascular Endothelial Growth Factor A
Liver Neoplasms
Colorectal Neoplasms
Colonic Neoplasms
Proto-Oncogene Proteins
ras Proteins
Biomarkers, Tumor
Indoles
Phosphatidylinositol 3-Kinases
Proto-Oncogene Proteins B-raf
Mutation
Sulfonamides
Benzimidazoles

To see the data from this visualization as text, click here.

Name	Number of Publications	First Publication Year	Most Recent Publication Year	Average Publication Date
src-Family Kinases	4	2007	2010	January 2009
Organoplatinum Compounds	15	2008	2014	October 2010
Antineoplastic Combined Chemotherapy Protocols	34	2007	2022	January 2011
Antineoplastic Agents	24	2005	2022	March 2011
Hepatectomy	18	2007	2014	May 2011
Drug Resistance, Neoplasm	8	2008	2013	August 2011
Vascular Endothelial Growth Factor A	3	2009	2013	August 2011
Liver Neoplasms	26	2007	2014	September 2011
Colorectal Neoplasms	66	2005	2022	January 2012
Colonic Neoplasms	11	2008	2020	August 2012
Proto-Oncogene Proteins	12	2009	2015	March 2013
ras Proteins	13	2009	2015	April 2013
Biomarkers, Tumor	15	2008	2017	July 2013
Indoles	3	2011	2015	July 2013
Phosphatidylinositol 3-Kinases	7	2011	2015	October 2013
Proto-Oncogene Proteins B-raf	17	2011	2022	May 2014
Mutation	26	2011	2022	October 2014
Sulfonamides	4	2011	2022	October 2015
Benzimidazoles	3	2012	2022	November 2018

KOPETZ's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (422)

Explore

Co-Authors (133)

Explore

Similar People (60)

Explore

Same Department

Explore